ICPerMed chair Mairead O'Driscoll says: “Personalised medicine is a new approach to healthcare, putting citizens at the centre of innovation. We expect this Action Plan to initiate joint research investments and activities necessary to tackle the complex implementation of personalised medicine.”
Hence it is the first time that such an impressive number of research funders and policy-makers have identified and published a consensus view on the research and development needed in order to further advance personalised medicine.
The Action Plan lists, 22 research and 8 supporting activities, which have been identified as ‘ready for action’. These span the whole healthcare value chain, from basic to clinical research until market access, and also take into account patient empowerment and sustainability of healthcare systems. ICPerMed regards this Action Plan as a blueprint for a coordinated approach for personalised medicine research and the reasonable implementation of innovative and promising approaches in the health systems.
Further information and a full list of ICPerMed members are available on the webpage: www.ICPerMed.eu
For inquiries, please contact the ICPerMed Secretariat:
phone: +49 228-3821-1266